JIN MEDICAL INTERNATIONAL LTD. (Class A) (ZJYL) exhibits 29.2% gross margins and 14.0% return on invested capital within Health Care (Industrial Specialties), balanced against a 47.1x enterprise multiple and 4.8% implied options volatility.
Sustained 29.2% gross profitability converts into 2.9% operating margin and 14.0% ROIC, outpacing sector cost of capital.
ROIC: 14.0% // GM: 29.2%YoY revenue trajectory of -12.0% paired with -1.27% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -12.0% // FCF YLD: -1.27%Altman Z-Score of 3.80 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.80 // F-SCORE: 4/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: 47.1xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $1.86 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Industrial Specialties require continuous execution to defend 5.8% net margins.
NET MARGIN: 5.8% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ZJYL & activate live FRED threshold breach alerts.